Fierce Pharma

JULY 19, 2024

While the national IT outrage caused by cybersecurity specialist CrowdStrike—and subsequently Microsoft—has grounded airlines and forced cancelations at hospitals, the experience from the meltdown | While the national IT outrage caused by cybersecurity specialist CrowdStrike—and subsequently Microsoft—has grounded airlines and forced cancelations at hospitals, the experience from the meltdown appeared different among large pharma companies.

Pharma 307

Pharma 307

MedCity News

JULY 19, 2024

A new eBook from MedCity News highlights the variety of technologies emerging from AI tech developers across the healthcare landscape from health tech startups to healthcare organizations, biopharma companies, and a medtech giant. It also explores the ethical issues AI in healthcare presents. The post The Shifting AI Landscape appeared first on MedCity News.

Ethics 119

Ethics Biopharma Healthcare Healthcare 119

Fierce Pharma

JULY 19, 2024

A 10-page Form 483 has detailed the shortfalls at Hengrui Pharma's PD-1 plant behind a recent FDA rejection. Sanofi is investing heavily to expand its global capacity center in India. | A 10-observation Form 483 has detailed the shortfalls at Hengrui Pharma's PD-1 plant behind its recent FDA rejection. Sanofi is investing heavily to expand its global capacity center in India.

Pharma 246

Pharma FDA 246

MedCity News

JULY 19, 2024

Harvard spinout GRO Biosciences has a platform technology for engineering therapeutic proteins that won’t prompt an immune response against them. The startup’s lead program is a potential competitor to an Amgen gout drug acquired in a multi-billion dollar deal. The post Aiming to Top Amgen in Gout, Startup GRObio Gets $60M to Enter the Clinic appeared first on MedCity News.

Engineering 116

Engineering Leads Biopharma 116

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Fierce Pharma

JULY 19, 2024

Back in February, Novo Holdings laid out a $16.5 billion deal to snap up contract manufacturing giant Catalent. | In February, Novo Holdings announced a $16.5 billion deal to acquire Catalent, and this week on "The Top Line," we explore the current state and implications of the proposed buyout.

Manufacturing 246

Manufacturing 246

pharmaphorum

JULY 19, 2024

FDA will create a rare disease hub to speed the development of new treatments and build connections between developers and the rare disease community

FDA 116

FDA 116

MedCity News

JULY 19, 2024

Profound opportunities and challenges are playing out at the intersection of the two. The post Policy Innovation Is Outpacing Technology at the Intersection of Health Care and Human Services appeared first on MedCity News.

113

113

PharmaTimes

JULY 19, 2024

LT-HSCs replenish blood cells after treatment for blood cancers, such as leukaemia

111

111

MedCity News

JULY 19, 2024

An opportunity for children to learn and grow in a supportive environment that prioritizes personalized treatment and transparent care The post Industry Review: ABA Therapy and Why It Is One of the Best Therapy Options for Children With Autism appeared first on MedCity News.

Patients 111

Patients 111

pharmaphorum

JULY 19, 2024

NICE backs NHS use of Accord's Orgovyx, the first therapy for advanced hormone-sensitive prostate cancer that can be taken at home

105

105

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

MedCity News

JULY 19, 2024

The integration of AI and human skills is poised to revolutionize surgical practices. The post Proprioceptive Precision: Transforming Surgery Through AI and Human Expertise appeared first on MedCity News.

111

111

pharmaphorum

JULY 19, 2024

While the pace of biotech private rounds seems to have slowed a little of late, this week saw four big financings for Cardurion Pharma, Scorpion Therapeutics, CatalYm, and NGM Bio.Burlington, Massachusetts-based Cardurion led the quartet with a $260 million Series B for its heart-focused drug pipeline, which features two candidates in phase 2 testing – PDE9 inhibitor CRD-750 for heart failure and CaMKII inhibitor CRD-4730 for rare genetic disease catecholaminergic polymorphic ventricular tachyca

Pharma 105

Pharma 105

MedCity News

JULY 19, 2024

Boehringer’s adalimumab-adbm is being offered on GoodRx’s platform for $550 per two-pack, a 92% discount from the Humira list price, according to the companies. The post GoodRx, Boehringer Ingelheim Launch Initiative for Humira Biosimilar appeared first on MedCity News.

109

109

Pharmaceutical Commerce

JULY 19, 2024

FDA to review one-year results for Susvimo showing non-inferior visual acuity gains in diabetic macular edema and in the Diabetic Retinopathy Severity Scale for Diabetic Retinopathy.

FDA 104

FDA Patients 104

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

pharmaphorum

JULY 19, 2024

Less than two years after pulling multiple myeloma therapy Blenrep off most markets around the world, GSK has filed for approval of the drug in the EU once again, hoping to restore its blockbuster credentials.The remarkable renaissance for the BCMA-directed antibody-drug conjugate is supported by a pair of phase 3 trials that could not only support its return but also make it an option for a much larger patient population than before.

Marketing 104

Marketing Patients 104

MedCity News

JULY 19, 2024

In one of the only pieces of health policy in the GOP’s 2024 platform, the former president vows not to cut Social Security or Medicare, the health program for older and disabled Americans, or change the federal retirement age. The post At the GOP Convention, There’s Little To Be Heard on Healthcare appeared first on MedCity News.

Healthcare 101

Healthcare Healthcare 101

PharmaTimes

JULY 19, 2024

Chronic pelvic pain is a disabling condition that affects around one in four women worldwide

Medicine 97

Medicine 97

PharmaVoice

JULY 19, 2024

The pharma company is tackling the “stiff person syndrome” that afflicts Celine Dion in a phase 2 trial for its lead CAR-T candidate.

Pharma 69

Pharma Leads 69

Advertisement

PharmaTimes

JULY 19, 2024

Accreditation recognises 'continued professional development' opportunities

94

94

Pharmaceutical Technology

JULY 19, 2024

New global projections and advances in HIV therapies are also on the agenda at the 25th International AIDS 2024 meeting.

Patients 64

Patients 64

PharmaVoice

JULY 19, 2024

Merdad Parsey joined Gilead as its chief medical officer in 2019 and has helped lead the company’s expansion into oncology, with mixed success.

Leads 59

Leads Medical 59

European Pharmaceutical Review

JULY 19, 2024

This report delves into the latest advances and developments impacting pharmaceutical drug formulators today. Inside, articles explore current vast expansion of the formulation including patient centricity, excipients, safety, quality and regulatory considerations. Stay up to date with the latest developments in drug formulation including articles on: The trends and challenges for OSD and patient centric formulations Cell and gene therapy formulation including the prominent issues and opportunit

Pharma 59

Pharma Manufacturing Pharmaceutical Safety 59

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

Clarivate

JULY 19, 2024

The Unitary Patent Court (UPC) has emerged as a new force in the global patent landscape. For the first time, it offers a means to enforce patents across 17 European states, creating an environment capable of rivaling other major global patent jurisdictions. The UPC aims to deliver highly effective relief to plaintiffs in terms of speed-to-decision, proportionality and cost.

Engineering 59

Engineering 59

Pharmacy Times

JULY 19, 2024

The importance of protecting the skin is often underestimated by patients

Patients 55

Patients 55

Pharmaceutical Technology

JULY 19, 2024

The Parker Institute for Cancer Immunotherapy was founded in 2016 by tech entrepreneur Sean Parker to bolster cancer research efforts.

52

52

Pharmacy Times

JULY 19, 2024

Individuals that followed the Mediterranean diet with EPA-DHA supplements displayed an increase in omega-3 levels which improved clinical appearance.

52

52

Advertisement

Distribution

Pharmaceutical Technology

JULY 19, 2024

The Opdivo/Yervoy combination demonstrated statistically and clinically significant improvements in the Phase III CheckMate-9DW study.

52

52

Pharmacy Times

JULY 19, 2024

There were positive efficacy and safety results for tivozanib monotherapy consistent with previous analyses.

Safety 52

Safety Patients 52

Pharmaceutical Technology

JULY 19, 2024

Exscientia paid $20m in upfront cash and equity to buy its development partner GT Apeiron’s shares for the CDK7 inhibitor.

52

52

PharmExec

JULY 19, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

Pharma 52

Pharma 52

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales